北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (1): 26-32. doi: 10.3969/j.issn.1671-167X.2018.01.005

• 论著 • 上一篇    下一篇

乏氧诱导因子-1α在口腔鳞状细胞癌颈淋巴转移中的作用

李健男1,冯芝恩2,王琳3,王衣祥3,郭传瑸3△   

  1. (1. 北京大学口腔医学院·口腔医院,综合科口腔数字化医疗技术和材料国家工程实验室口腔数字医学北京市重点实验室, 北京100081;2.首都医科大学附属北京口腔医院口腔颌面头颈肿瘤科, 北京100050;3. 北京大学口腔医学院·口腔医院口腔颌面外科, 北京100081)
  • 出版日期:2018-02-18 发布日期:2018-02-18
  • 通讯作者: 郭传瑸 E-mail:guodazuo@sina.com
  • 基金资助:
    国家自然科学基金(81470707)资助

Expression of hypoxiainducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma

LI Jian-nan1, FENG Zhi-en2, WANG Lin3, WANG Yi-xiang3, GUO Chuan-bin3△   

  1. (1. Department of General Dentistry, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China; 2. Department of Oral and MaxillofacialHead and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing 100050, China; 3. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China)
  • Online:2018-02-18 Published:2018-02-18
  • Contact: GUO Chuan-bin E-mail:guodazuo@sina.com
  • Supported by:
    Supported by the National Natural Science Foundation of China (81470707)

摘要: 目的:探讨乏氧诱导因子-1α(hypoxia-inducible factor 1α,HIF-1α)蛋白表达在口腔鳞状细胞癌颈淋巴转移中的作用及其在判断预后方面的意义。方法:1993年6月至2010年5月在北京大学口腔医院住院并接受手术治疗的原发口腔鳞状细胞癌患者125例纳入本次研究,收集所有患者的临床病理学资料,制作组织病理切片,应用免疫组织化学方法检测HIF-1α蛋白的表达情况,根据表达情况分为高表达组和低表达组,主要评估指标为颈淋巴转移率和癌相关生存率(disease-specific survival,DSS)。颈淋巴转移率与各项临床病理学参数的关系比较采用秩和检验,组间及组内癌相关生存率的差异性比较采用Kaplan-Meier分析,并应用COX多因素生存分析对DSS的独立预测因子进行统计分析。所有统计学分析均采用SPSS 17.0软件包完成。结果:随访截止日期为2013年6月1日,生存患者的中位随访时间为73个月,有75例HIF-1α高表达,48例HIF1α低表达,2例无法评估。秩和检验分析发现,HIF-1α高表达组淋巴转移率显著高于HIF-1α低表达组(58.7% vs. 37.5%,P=0.027)。Kaplan-Meier生存分析发现,HIF-1α低表达组患者无病生存率显著高于高表达组(60.4% vs. 36.0%,P=0.009), 癌相关生存率显著高于高表达组(70.8% vs. 46.7%,P=0.005)。多因素生存分析表明,HIF-1α表达(HR=2.164,95%CI:1.150~4.074,P=0.017)和T分期(HR=1.387,95%CI:1.066~1.804,P=0.015)均是判断口腔鳞状细胞癌患者预后的独立预测因子。结论:HIF-1α蛋白表达是预测口腔鳞状细胞癌预后的独立因子,且与颈淋巴转移显著相关,能够作为口腔鳞状细胞癌潜在的分子诊断标志物和靶向治疗靶点。

关键词: 乏氧诱导因子1α, 癌, 鳞状细胞, 头颈部肿瘤, 淋巴转移, 预后

Abstract: Objective: To explore the association between hypoxia-inducible factor 1α (HIF-1α) expression and lymph node metastasis in oral squamous cell carcinoma (OSCC). Methods: Tumor specimens from 125 patients with histologically-proven, surgically-treated OSCC were examined by immunohistochemical staining for expression of HIF-1α. The patients were divided into two groups by the expression of HIF-1α, high expression of HIF-1α group (H-group) and low expression of HIF-1α group (L-group). The main assessment parameters were lymph node metastasis rate and disease-specific survival (DSS). The lymph node metastasis rate and clinicopathologic features were compared using Mann-Whitney test. The Kaplan-Meier curve was generated for each group and compared using the log-rank test. Cox proportional hazard models were utilized for multivariate analyses of HIF-1α expression and other baseline factors with DSS. All calculations and analyses were performed using the SPSS 17.0 software package. Results: The protein expression levels of HIF-1α were up-regulated in OSCC and two patients were unable to evaluate. There were 48 patients in L-group and 75 patients in H-group. Lymph node metastasis rate was 37.5% (18/48) for L-group and 58.7% (44/75) for H-group (P=0.027). Expression of HIF-1α was significantly correlated with lymph node metastasis. The patients of L-group had a significantly better DSS than the patients of Hgroup (70.8% vs. 46.7%, P=0.005), while the patients of L-group had a significantly better disease-free survival (DFS ) than the patients of H-group (60.4% vs. 36.0%, P=0.009) by Kaplan-Meier method. A multivariate survival analysis also showed that HIF-1α expression (HR=2.164, 95%CI: 1.150-4.074, P=0.017) and Tstage (HR=1.387, 95%CI: 1.066-1.804, P=0.015) both were the independent factors associated with prognosis. Conclusion: HIF-1α expression is significantly correlated with lymph node metastasis in OSCC. HIF-1α expression is an independent predictive factor for prognosis of OSCC patients, and may serve as a potential biomarker for molecular diagnosis and targeted therapy in future.

Key words: Hypoxia-inducible factor 1α, Carcinoma, squamous cell, Head and neck neoplasms, Lymphatic metastasis, Prognosis

中图分类号: 

  • R739.8
[1] 步召德, 冯梦宇, 季科. 早期胃癌行前哨淋巴结导航手术的实践与思考[J]. 北京大学学报(医学版), 2026, 58(2): 239-243.
[2] 王海, 江一舟. 靶向血管治疗在乳腺癌精准治疗中的分子机制与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 251-256.
[3] 罗必显, 刘洪铭, 谢伟勋, 龚渭华. 产甲胎蛋白胃癌的新临床特征和前沿科学问题[J]. 北京大学学报(医学版), 2026, 58(2): 257-265.
[4] 付浩, 申潞艳, 黄冰洋, 马少华. 免疫治疗背景下食管鳞状细胞癌围手术期治疗的临床思考[J]. 北京大学学报(医学版), 2026, 58(2): 266-271.
[5] 殷昊明, 王子杰, 舒帆, 张展奕, 梁会, 张树栋. 肾透明细胞癌FABP6基因长转录本的表达及意义[J]. 北京大学学报(医学版), 2026, 58(2): 393-398.
[6] 李嘉临, 陈力侨, 唐家天, 吴艳, 王安强. 胃肝样腺癌转化治疗1例[J]. 北京大学学报(医学版), 2026, 58(2): 399-404.
[7] 郭芷均, 俎明, 马超, 张贺军, 张静, 丁士刚. 同时性多发早期胃癌漏诊病灶的临床病理特征[J]. 北京大学学报(医学版), 2026, 58(2): 410-415.
[8] 潘子晨, 陈凯, 侯钰坤, 杨博涵, 张继新, 马永蔌, 田孝东, 杨尹默. 胰腺腺鳞癌临床病理特征与分子机制研究进展[J]. 北京大学学报(医学版), 2026, 58(2): 431-435.
[9] 张铃福, 陈明, 赵小宇, 王港, 崔龙, 凌晓锋, 王立新, 徐智, 郭丽梅, 侯纯升. 原发灶局限于胆囊壁内胆囊癌大体分型及其与预后和癌前病变的相关性[J]. 北京大学学报(医学版), 2026, 58(1): 184-189.
[10] 高雅静, 李正芳, 马梦思, 武丽君. SII和SIRI对白塞病葡萄膜炎的风险预测及疾病活动度和预后的评估[J]. 北京大学学报(医学版), 2025, 57(6): 1067-1073.
[11] 王晓林, 李璐瑶, 张雯, 王鸿雁. 3例子宫体中肾样腺癌的临床病理学分析[J]. 北京大学学报(医学版), 2025, 57(6): 1208-1212.
[12] 侯卫华, 宋书杰, 石中月, 刘露, 金木兰. 食管胃结合部具有显著空泡状核特征的神经内分泌癌1例[J]. 北京大学学报(医学版), 2025, 57(5): 1005-1009.
[13] 谢尚, 王鹿鸣, 张馨元, 冯秋实, 夏洋洋, 戴姿薇, 单小峰, 蔡志刚. 口腔鳞癌类器官库的构建及应用[J]. 北京大学学报(医学版), 2025, 57(5): 847-851.
[14] 李浙民, 季加孚, 李国新, 李子禹, 步召德, 高翔宇, 董迪, 唐磊, 邢晓芳, 贾淑芹, 郭婷, 张连海, 陕飞, 季鑫, 王安强. 胃癌精准诊疗技术的创建与推广[J]. 北京大学学报(医学版), 2025, 57(5): 864-867.
[15] 唐少海, 杨宝明, 李建坤, 赵丽丽, 王仪凡, 王顺祥. HDAC2介导H3K27ac修饰促进肝癌细胞的增殖和迁移[J]. 北京大学学报(医学版), 2025, 57(5): 884-894.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!